A detailed history of Dimensional Fund Advisors LP transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 76,086 shares of LXRX stock, worth $61,629. This represents 0.0% of its overall portfolio holdings.

Number of Shares
76,086
Previous 76,086 -0.0%
Holding current value
$61,629
Previous $127,000 6.3%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$1.54 - $2.28 $40,260 - $59,606
26,143 Added 52.35%
76,086 $127,000
Q1 2024

May 10, 2024

BUY
$1.3 - $3.58 $64,925 - $178,795
49,943 New
49,943 $119,000
Q3 2023

Nov 09, 2023

SELL
$1.06 - $2.33 $458,897 - $1.01 Million
-432,922 Reduced 58.21%
310,815 $338,000
Q2 2023

Aug 09, 2023

BUY
$2.15 - $3.49 $52,793 - $85,696
24,555 Added 3.41%
743,737 $1.7 Million
Q1 2023

May 12, 2023

BUY
$1.99 - $2.68 $609,704 - $821,109
306,384 Added 74.22%
719,182 $1.75 Million
Q4 2022

Feb 09, 2023

SELL
$1.8 - $2.56 $90,702 - $128,998
-50,390 Reduced 10.88%
412,798 $788,000
Q3 2022

Nov 10, 2022

SELL
$1.94 - $3.43 $391,104 - $691,488
-201,600 Reduced 30.33%
463,188 $1.11 Million
Q2 2022

Aug 12, 2022

SELL
$1.31 - $2.69 $268,318 - $550,973
-204,823 Reduced 23.55%
664,788 $1.24 Million
Q1 2022

May 13, 2022

BUY
$1.95 - $3.89 $188,434 - $375,902
96,633 Added 12.5%
869,611 $1.82 Million
Q4 2021

Feb 09, 2022

BUY
$3.81 - $6.16 $1.06 Million - $1.71 Million
277,540 Added 56.02%
772,978 $3.05 Million
Q3 2021

Nov 12, 2021

SELL
$3.38 - $5.35 $156,213 - $247,260
-46,217 Reduced 8.53%
495,438 $2.38 Million
Q2 2021

Aug 12, 2021

BUY
$4.12 - $5.87 $2.23 Million - $3.18 Million
541,655 New
541,655 $2.49 Million
Q1 2021

May 14, 2021

SELL
$3.45 - $9.09 $57,884 - $152,512
-16,778 Closed
0 $0
Q4 2020

Feb 25, 2021

BUY
$1.05 - $3.67 $17,616 - $61,575
16,778 New
16,778 $57,000

Others Institutions Holding LXRX

About LEXICON PHARMACEUTICALS, INC.


  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $153M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.